Hyperglycemia induces PAI-1 gene expression in adipose tissue by activation of the hexosamine biosynthetic pathway (Q43833280)

27 November 2017

Hyperglycemia induces PAI-1 gene expression in adipose tissue by activation of the hexosamine biosynthetic pathway (English)

1 reference

27 November 2017

1 reference

6

Nir Barzilai

1 reference

27 November 2017

1

Ilan Gabriely

1 reference

27 November 2017

Xiao Man Yang

2

1 reference

27 November 2017

Jane A Cases

series ordinal

3

1 reference

27 November 2017

Xiao Hui Ma

series ordinal

4

1 reference

27 November 2017

Luciano Rossetti

series ordinal

5

1 reference

27 November 2017

1 January 2002

1 reference

27 November 2017

1 reference

27 November 2017

160

1 reference

27 November 2017

1

1 reference

27 November 2017

115-122

1 reference

Obesity, atherosclerosis, and coronary artery disease

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

The metabolic syndrome X.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Haemostatic function and cardiovascular death: early results of a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Fibrinogen as a risk factor for stroke and myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Haemostatic factors and atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Induction of type 1 plasminogen activator inhibitor in human liver ischemia and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic and Type 2 diabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Augmentation of arterial endothelial cell expression of the plasminogen activator inhibitor type-1 (PAI-1) gene by proinsulin and insulin in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Sustained improvement in blood lipids, coagulation, and fibrinolysis after major weight loss in obese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Beneficial effect of a moderately energy-restricted diet on fibrinolytic factors in non-obese men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Circadian Variation of Fibrinolytic Activity in Blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

A nutrient-sensing pathway regulates leptin gene expression in muscle and fat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Transcriptional regulation of transforming growth factor beta1 by glucose: investigation into the role of the hexosamine biosynthesis pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Role of the glucosamine pathway in fat-induced insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Assessment of insulin sensitivity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Surgical removal of visceral fat reverses hepatic insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Insulin sensitivity, insulin action, and fibrinolysis activity in nondiabetic and diabetic obese subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

Influence of changes in lifestyle on fibrinolytic parameters and recurrence rate in patients with venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

A high concentration of glucose alters the production of tPA, uPA and PAI-1 antigens from human mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

The adipocyte and hemostatic balance in obesity: studies of PAI-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900574-3

10.1016/S0021-9150(01)00574-3

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference